Version 5.4
Bos taurus Protein: CSRNP3
Summary
InnateDB Protein IDBP-693430.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CSRNP3
Protein Name cysteine/serine-rich nuclear protein 3
Synonyms FAM130A2;
Species Bos taurus
Ensembl Protein ENSBTAP00000031338
InnateDB Gene IDBG-641107 (CSRNP3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0001228 RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0043565 sequence-specific DNA binding
Biological Process
GO:0010923 negative regulation of phosphatase activity
GO:0043065 positive regulation of apoptotic process
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR023260 Cysteine/serine-rich nuclear protein family
PFAM
PRINTS PR02031
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q1LZE5
UniProt Splice Variant
Entrez Gene 540832
UniGene Bt.63508
RefSeq NP_001069712
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC116047 DAAA02004360
GenPept AAI16048

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca